Actis to invest $42m in India’s Paras Pharmaceuticals

Actis, a UK Private equity firm, is investing $42 million to fund the expansion of an Indian over-the-counter healthcare and personal care business.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this